Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
Clinical Sequencing Project for Early Gastric Cancer and Precancerous Gastric Adenoma Patients for Personalized Cancer Clinic
Sponsor: Samsung Medical Center
This observational or N/A phase trial investigates Early Gastric Cancer and Gastric Adenoma and is currently actively recruiting participants. Samsung Medical Center leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Recruiting
Status: Unknown → Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Dec 2021 — Feb 2023 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .